Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC

Clinical trial NCT04699721 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04699721
Sponsor: Xiangya Hospital of Central South University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Stage II Non-small Cell Lung Cancer Stage ⅢA Non-small Cell Lung Cancer Stage IIIB

Start date: 2020-07-01
Primary completion: 2027-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.